국내 침습성 폐 아스페르길루스증의 역학 및 임상특징: 앞으로의 과제
Epidemiology and Clinical Characteristics of Invasive Pulmonary Aspergillosis in Korea: Tasks for the Future
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Invasive pulmonary aspergillosis (IPA) is a leading cause of morbididy and mortality for patients with malignancy and transplantation recipients. Recent advances in diagnosis and treatment strategies can improve patients’ survival. In addition, because the epidemiologies of invasive fungal infections would differ between Korea and Western countries, Organization of a nationwide network in collaboration with infectious diseases specialists, medical microbiologists, and government personnels is also anticipated. Due to a restricted reimbursement system in Korea, current clinical practices for treatment of IPA are limited. According to the textbooks and guidelines from results of well designed clinical trials and extensive clinical experiences, criteria for insurance benefits should be improved in the near future.
Abstract
Invasive pulmonary aspergillosis (IPA) is a leading cause of morbididy and mortality for patients with malignancy and transplantation recipients. Recent advances in diagnosis and treatment strategies can improve patients’ survival. In addition, because the epidemiologies of invasive fungal infections would differ between Korea and Western countries, Organization of a nationwide network in collaboration with infectious diseases specialists, medical microbiologists, and government personnels is also anticipated. Due to a restricted reimbursement system in Korea, current clinical practices for treatment of IPA are limited. According to the textbooks and guidelines from results of well designed clinical trials and extensive clinical experiences, criteria for insurance benefits should be improved in the near future.
참고문헌 (11)
- 강철인, "침습성 아스페르길루스증의 발생 양상과 치료결과", Infection and Chemotherapy, 34(3), pp.160~166 (2002), 대한감염학회
- 유진홍, "혈액질환 환자에서 조혈모세포 이식과화학요법 후의 침습성 진균감염의 분석", Infection and Chemotherapy, 36(1), pp.40~45 (2004), 대한감염학회
- Jong Man Kim, "Aspergillosis in Liver Transplant Recipients: A Single Center Experience", 대한외과학회지, 79(4), pp.267~274 (2010), 대한외과학회
- 김성한, "침습성 폐 아스페르길루스증의 역학과 임상상: 전국 다기관 연구", Infection and Chemotherapy, 44(4), pp.282~288 (2012), 대한감염학회
- de Pauw B., "Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer", Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group(EORTC, Clin Infect Dis, pp.2008, 46[DOI]
- Bergeron A., "The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies", Blood, 119, pp.1831~1837 (2012)
- Herbrecht R., "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis", N Engl J Med, 347, pp.408~415 (2002)
- Walsh TJ., "Treatment of aspergillosis : clinical practice guidelines of the Infectious Diseases Society of America", Clin Infect Dis, 46, pp.327~360 (2008)
- 최수미, "국내 혈액질환 환자에서 침습성 진균 감염의 구제치료로서 Caspofungin의 효과와 안전성", Infection and Chemotherapy, 37(5), pp.247~254 (2005), 대한감염학회
- 권재철, "국내 혈액질환 환자에서 침습성 아스페르길루스증의 구제치료로서 Voriconazole의 효과와 안전성", Infection and Chemotherapy, 42(1), pp.17~22 (2010), 대한감염학회
- Upton A., "Invasive aspergillosis following hematopoietic cell transplantation : outcomes and prognostic factors associated with mortality", Clin Infect Dis, 44, pp.531~540 (2007)